The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label, multicenter, blank-controlled, phase IV clinical trial of Biyan Qingdu Granula in attenuating acute nose and oral damage in patients undergoing radiotherapy for nasopharyngeal carcinoma.
 
Zhigang Liu
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Zunbei Wen
No Relationships to Disclose
 
Xin Wu
No Relationships to Disclose
 
Li Bai
No Relationships to Disclose
 
Deming Xu
No Relationships to Disclose
 
Huaming Lin
No Relationships to Disclose
 
Haichao Lin
No Relationships to Disclose
 
Jiemei Tan
No Relationships to Disclose
 
Wei Wu
No Relationships to Disclose
 
Weijun Zhang
No Relationships to Disclose
 
Sufang Qiu
No Relationships to Disclose
 
Yimin Liu
No Relationships to Disclose
 
Haisheng Zhu
No Relationships to Disclose
 
Xiaowen Zhang
No Relationships to Disclose
 
Yanhua Xu
No Relationships to Disclose
 
Dehua Wu
No Relationships to Disclose
 
Junlin Yi
No Relationships to Disclose
 
Yan Ruan
No Relationships to Disclose
 
Yexiong Li
No Relationships to Disclose
 
Biyan Qingdu Granula
No Relationships to Disclose